Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Titan Medical Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.05 |
52 Week High | CA$0.25 |
52 Week Low | CA$0.05 |
Beta | 2.01 |
1 Month Change | -16.67% |
3 Month Change | -41.18% |
1 Year Change | -76.19% |
3 Year Change | -97.77% |
5 Year Change | -98.39% |
Change since IPO | -99.70% |
Recent News & Updates
Revenues Working Against Titan Medical Inc.'s (TSE:TMD) Share Price
Jan 09There's No Escaping Titan Medical Inc.'s (TSE:TMD) Muted Revenues
Sep 25Shareholder Returns
TMD | CA Medical Equipment | CA Market | |
---|---|---|---|
7D | -9.1% | -3.0% | -1.9% |
1Y | -76.2% | -30.7% | 12.2% |
Return vs Industry: TMD underperformed the Canadian Medical Equipment industry which returned -30.7% over the past year.
Return vs Market: TMD underperformed the Canadian Market which returned 12.2% over the past year.
Price Volatility
TMD volatility | |
---|---|
TMD Average Weekly Movement | 15.0% |
Medical Equipment Industry Average Movement | 10.6% |
Market Average Movement | 8.8% |
10% most volatile stocks in CA Market | 17.4% |
10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: TMD's share price has been volatile over the past 3 months.
Volatility Over Time: TMD's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 4 | Paul Cataford | www.titanmedicalinc.com |
Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.
Titan Medical Inc. Fundamentals Summary
TMD fundamental statistics | |
---|---|
Market cap | CA$5.70m |
Earnings (TTM) | CA$11.92m |
Revenue (TTM) | CA$24.10m |
0.5x
P/E Ratio0.2x
P/S RatioIs TMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TMD income statement (TTM) | |
---|---|
Revenue | US$17.63m |
Cost of Revenue | US$0 |
Gross Profit | US$17.63m |
Other Expenses | US$8.92m |
Earnings | US$8.72m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.076 |
Gross Margin | 100.00% |
Net Profit Margin | 49.44% |
Debt/Equity Ratio | 0% |
How did TMD perform over the long term?
See historical performance and comparison